UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies basliginda one cikan gelisme: AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.